Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Data on peritoneal metastases (PM) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are scarce.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Madani A
Authors: Madani A, Thomassen I, Van Gestel Y, Van Der Bilt J, Haak H,
Keywords: peritoneal metastases, peritoneal carcinomatosis, gastroenteropancreatic neuroendocrine tumors, GEP-NETs, prognosis ,
#707 Neuroendocrine Carcinoma: Surgery of Peritoneal Metastasis
Introduction: Neuroendocrine tumor (NET)-derived peritoneal metastases (PM) are not really described nor taken into account in the literature, yet they exert an impact on overall survival (OS)
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: Dumont F
Authors: Elias D, David A, Sourouille I, Honoré C, Goéré D,
Keywords: neuroendocrine tumor, peritoneal metastases, hyperthermic intraperitoneal chemotherapy,
#523 Metastatic Midgut Carcinoid Tumors: 20-years Experience in a Single Center
Introduction: The prognosis of metastatic midgut carcinoids has improved during the last decade, due to the increasing number of therapeutic options.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Moletta L, Milanetto A, Alaggio R, Sperti C, Pedrazzoli S,
Keywords: midgut carcinoid tumors, metastatic tumors,
#241 One-year Response to Everolimus in a Case of Advanced Pancreatic NET
Introduction: A stage IV pancreatic NET (30 mitoses/10 PF and Ki-67 index=40%) with liver and peritoneal metastases was diagnosed in a 35-year-old woman in June 2008. Characteristics: ECOG2 and CgA 1701 ng/ml.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: J Fonseca P, Vietez J, Galvan J, Crespo G, Astudillo A,
Keywords: pancreatic neuroendocrine tumor, Everolimus, Somatostatin Analogues, chemotherapy,
#137 Extensive ""multitasking"" surgery for advanced neuroendocrine tumors is safe and effective
Introduction: Management of advanced NETs is controversial, related to degree of intervention; the pendulum is swinging towards a more aggressive interventional approach. Our Center's philosophy is to offer a systematic, planned multimodality treatment for patients with advanced NETs.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author: Shafir M
Authors: Shafir M, Warner R, Gonsalves S, Zacks J, Ratner L,
Keywords: extensive surgery, advanced NETs,